← Back to KALA

KALA BIO, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 19/08/2026Mar 2026Filed 15/05/2026Sep 2025Filed 19/11/2025Jun 2025Filed 19/08/2026Mar 2025Filed 15/05/2026Sep 2024Filed 19/11/2025Jun 2024Filed 08/08/2025Mar 2024Filed 14/05/2025
−$1.6−$1.6−$7.6−$11−$8.9−$9−$9.6−$12
−$21.32−$0.14−$1.07−$85.64−$70.49−$1.93−$3.16−$4.20
74.632.8

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.